Literature DB >> 2404511

Immunohistological distribution of 5T4 antigen in normal and malignant tissues.

P J Southall1, G M Boxer, K D Bagshawe, N Hole, M Bromley, P L Stern.   

Abstract

A trophoblast cell surface antigen has been characterised by a monoclonal antibody (mAb) 5T4, raised following immunisation with solubilised wheat germ agglutinin binding glycoproteins from human syncytiotrophoblast plasma membrane (StMPM). The expression of the 72 kDa glycoprotein was assessed on cryostat sections of a range of neoplastic and non-neoplastic tissues, using an avidin-biotin immunoperoxidase technique. In products of conception, intense reactions were noted with villous syncytiotrophoblast membrane in normal early and term placenta, with weaker positivity of placental site trophoblast. Most normal or non-neoplastic tissues were negative, including liver, kidney, spleen, small intestine, ovary and testis. Faint or moderate positive reactions were present in some specialised epithelia. Of 115 neoplasms examined, 76 showed reactions with tumour cells including carcinomas of the bladder, breast, cervix, endometrium, lung, oesophagus, ovary, pancreas, stomach and testicular non-seminomatous germ cell tumours. Choriocarcinomas and placental site trophoblastic tumours were also positive. Most adenocarcinomas of colon and seminomas were negative as were all malignant melanomas and malignant lymphomas. A radioimmunoassay did not detect the antigen in either normal or pregnancy serum. The relatively low level of expression in normal tissues and reactivity with a wide range of carcinomas suggested that the antibody may be useful in diagnostic or targeting studies.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2404511      PMCID: PMC1971328          DOI: 10.1038/bjc.1990.20

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  10 in total

1.  Characterization of the human trophoblast-leukocyte antigenic molecules defined by a monoclonal antibody.

Authors:  P L Stern; N Beresford; S Thompson; P M Johnson; P D Webb; N Hole
Journal:  J Immunol       Date:  1986-09-01       Impact factor: 5.422

2.  Identification of cytotrophoblast colonies in cultures of human placental cells using monoclonal antibodies.

Authors:  Y W Loke; B H Butterworth; J J Margetts; K Burland
Journal:  Placenta       Date:  1986 May-Jun       Impact factor: 3.481

3.  Indium-111 labelled monoclonal antibody to placental alkaline phosphatase in in the detection of neoplasms of testis, ovary, and cervix.

Authors:  A A Epenetos; D Snook; G Hooker; R Begent; H Durbin; R T Oliver; W F Bodmer; J P Lavender
Journal:  Lancet       Date:  1985-08-17       Impact factor: 79.321

4.  Expression on cultured human tumour cells of placental trophoblast membrane antigens and placental alkaline phosphatase defined by monoclonal antibodies.

Authors:  P J McLaughlin; M H Cheng; M B Slade; P M Johnson
Journal:  Int J Cancer       Date:  1982-07-15       Impact factor: 7.396

5.  Purification and biochemical characterization of human pluripotent hematopoietic colony-stimulating factor.

Authors:  K Welte; E Platzer; L Lu; J L Gabrilove; E Levi; R Mertelsmann; M A Moore
Journal:  Proc Natl Acad Sci U S A       Date:  1985-03       Impact factor: 11.205

6.  Placental-type alkaline phosphatase in pregnancy and malignancy plasma: specific estimation using a monoclonal antibody in a solid phase enzyme immunoassay.

Authors:  P J McLaughlin; H Gee; P M Johnson
Journal:  Clin Chim Acta       Date:  1983-05-30       Impact factor: 3.786

7.  Carcinoembryonic antigen production, secretion, and kinetics in BALB/c mice and a nude mouse-human tumor model.

Authors:  K W Martin; S E Halpern
Journal:  Cancer Res       Date:  1984-12       Impact factor: 12.701

8.  A 72 kD trophoblast glycoprotein defined by a monoclonal antibody.

Authors:  N Hole; P L Stern
Journal:  Br J Cancer       Date:  1988-03       Impact factor: 7.640

9.  Urinary gonadotrophin peptide--isolation and purification, and its immunohistochemical distribution in normal and neoplastic tissues.

Authors:  A Kardana; M E Taylor; P J Southall; G M Boxer; A J Rowan; K D Bagshawe
Journal:  Br J Cancer       Date:  1988-09       Impact factor: 7.640

10.  An immunohistological study of testicular germ cell tumours using two different monoclonal antibodies against placental alkaline phosphatase.

Authors:  A A Epenetos; P Travers; K C Gatter; R D Oliver; D Y Mason; W F Bodmer
Journal:  Br J Cancer       Date:  1984-01       Impact factor: 7.640

  10 in total
  60 in total

Review 1.  Neoadjuvant chemoimmunotherapy in locally advanced breast cancer: a new avenue to be explored.

Authors:  Jan Buter; Herbert M Pinedo
Journal:  Curr Oncol Rep       Date:  2003-05       Impact factor: 5.075

2.  Identification of a major histocompatibility complex class I-restricted T-cell epitope in the tumour-associated antigen, 5T4.

Authors:  Irina Redchenko; Richard Harrop; Matthew G Ryan; Robert E Hawkins; Miles W Carroll
Journal:  Immunology       Date:  2006-05       Impact factor: 7.397

Review 3.  Update on prostate cancer vaccines.

Authors:  Charles G Drake
Journal:  Cancer J       Date:  2011 Sep-Oct       Impact factor: 3.360

4.  A novel 5T4-targeting antibody-drug conjugate H6-DM4 exhibits potent therapeutic efficacy in gastrointestinal tumor xenograft models.

Authors:  Ruixue Wang; Qinhuai Lai; Liangze Tang; Yiran Tao; Yuqin Yao; Yu Liu; Ying Lu; Chaoyong Shen; Ran Lu; Chuanwen Fan; Ruirui Zhang; Yuxi Wang; Lin Yu; Tinghan Yang; Yangping Wu; Yujia Peng; Xian Wei; Yuyin Fu; Weirong Lai; Lantu Gou; Jinliang Yang
Journal:  Am J Cancer Res       Date:  2018-04-01       Impact factor: 6.166

5.  CD8+ T-cell clones specific for the 5T4 antigen target renal cell carcinoma tumor-initiating cells in a murine xenograft model.

Authors:  Scott S Tykodi; Shoko Satoh; Janise D Deming; Jeffrey Chou; Richard Harrop; Edus H Warren
Journal:  J Immunother       Date:  2012-09       Impact factor: 4.456

6.  Glycosylation and epitope mapping of the 5T4 glycoprotein oncofoetal antigen.

Authors:  David M Shaw; Andrew M Woods; Kevin A Myers; Caroline Westwater; Veena Rahi-Saund; Michael J Davies; David V Renouf; Elizabeth F Hounsell; Peter L Stern
Journal:  Biochem J       Date:  2002-04-01       Impact factor: 3.857

Review 7.  Novel cancer antigens for personalized immunotherapies: latest evidence and clinical potential.

Authors:  Gregory T Wurz; Chiao-Jung Kao; Michael W DeGregorio
Journal:  Ther Adv Med Oncol       Date:  2016-01       Impact factor: 8.168

8.  Scatter factor influences the formation of prostate epithelial cell colonies on bone marrow stroma in vitro.

Authors:  S H Lang; N W Clarke; N J George; N G Testa
Journal:  Clin Exp Metastasis       Date:  1999-06       Impact factor: 5.150

Review 9.  Development of modified vaccinia Ankara-5T4 as specific immunotherapy for advanced human cancer.

Authors:  Scott S Tykodi; John A Thompson
Journal:  Expert Opin Biol Ther       Date:  2008-12       Impact factor: 4.388

10.  CXCR4 mediated chemotaxis is regulated by 5T4 oncofetal glycoprotein in mouse embryonic cells.

Authors:  Thomas D Southgate; Owen J McGinn; Fernanda V Castro; Andrzej J Rutkowski; Mariam Al-Muftah; Georgi Marinov; Graeme J Smethurst; David Shaw; Christopher M Ward; Crispin J Miller; Peter L Stern
Journal:  PLoS One       Date:  2010-04-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.